EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons

Rafael Rivas-Santisteban, Iu Raïch iD, David Aguinaga, Carlos A Saura iD, Rafael Franco iD, Gemma Navarro iD

Cells · 2023

DOI: 10.3390/cells12020283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Rafael Rivas-Santisteban und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: US Alzheimer’s Association, Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU; or equivalent), Spanish Agencia Estatal de Investigación (AEI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The N-methyl-D-aspartate receptor (NMDAR) is a target in current treatments for Alzheimer’s disease (AD). The human prion protein (PrPC) has an important role in the pathophysiology of AD. We hypothesized that PrPC modulates NMDA signaling, thus being a process associated with Alzheimer’s disease.

Methods

NMDAR signaling was characterized in the absence or presence of PrPC in cAMP level determination, mitogen-activated protein kinase (MAPK) pathway and label-free assays in homologous and heterologous systems. Bioluminescence resonance energy transfer was used to detect the formation of NMDAR-PrPC complexes. AXIS™ Axon Isolation Devices were used to determine axonal transport of Tau and pTau proteins in cortical primary neurons in the absence or presence of PrPC. Finally, proximity ligation assays were used to quantify NMDA-PrPC complex formation in neuronal primary cultures isolated from APPSw/Ind transgenic mice, an Alzheimer’s disease model expressing the Indiana and Swedish mutated version of the human amyloid precursor protein (APP).

Results

We discovered a direct interaction between the PrPC and the NMDAR and we found a negative modulation of NMDAR-mediated signaling due to the NMDAR-PrPC interaction. In mice primary neurons, we identified NMDA-PrPC complexes where PrPC was capable of blocking NMDAR-mediated effects. In addition, we observed how the presence of PrPC results in increased neurotoxicity and neuronal death. Similarly, in microglial primary cultures, we observed that PrPC caused a blockade of the NMDA receptor link to the MAPK signaling cascade. Interestingly, a significant increase in NMDA-PrPC macromolecular complexes was observed in cortical neurons isolated from the APPSw,Ind transgenic model of AD.

Conclusions

PrPC can interact with the NMDAR, and the interaction results in the alteration of the receptor functionality. NMDAR-PrPC complexes are overexpressed in neurons of APPSw/Ind mouse brain. In addition, PrPC exacerbates axonal transport of Tau and pTau proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMiceHumansAnimalsReceptors, N-Methyl-D-AspartatePrion ProteinsN-MethylaspartatePhosphorylationNeuronsAmyloid beta-Protein PrecursorMice, Transgenic

Stichwörter der Autor:innen

Alzheimer’s diseaseNMDATau proteinaxonal transportpTau proteinprion protein

Substanzen

Receptors, N-Methyl-D-AspartatePrion ProteinsN-MethylaspartateAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain.
  • Departament de Bioquímica i Biomedicina Molecular, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Institute of Neuroscience (NeuroUB), University of Barcelona, Av. Joan XXIII 27-31, 08028 Barcelona, Spain.
  • Department de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
  • Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain.
  • School of Chemistry, University of Barcelona, 08028 Barcelona, Spain.

ORCID-Profile: Iu Raïch, Carlos A Saura, Rafael Franco, Gemma Navarro

Förderung

  • US Alzheimer’s Association
  • Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU; or equivalent)
  • Spanish Agencia Estatal de Investigación (AEI)

Zitieren

APA

Rivas-Santisteban, R., Raïch, I., Aguinaga, D., Saura, C. A., Franco, R., & Navarro, G. (2023). The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons. Cells. https://doi.org/10.3390/cells12020283

Vancouver

Rivas-Santisteban R, Raïch I, Aguinaga D, Saura CA, Franco R, Navarro G. The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons. Cells. 2023. doi:10.3390/cells12020283

BibTeX
@article{RivasSantisteban2023,
  author = {Rivas-Santisteban, Rafael and Raïch, Iu and Aguinaga, David and Saura, Carlos A and Franco, Rafael and Navarro, Gemma},
  title = {The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12020283}
}
Kostenlos starten →